Search

everythinglearnresearchcommunity

for

Search:↓

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Polycystic Ovary Syndrome (PCOS) in teenagers is a complex condition linked to genetics and environment, often associated with obesity and insulin resistance, and is treated with lifestyle changes and medication.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

New genes linked to male pattern baldness were found on chromosome 20p11.

These gene variations are not linked to alopecia areata in Egyptians.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Finger length ratios might help predict common hair loss.

Certain genes are linked to the risk of developing Alopecia Areata.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Understanding the Y chromosome is key to male health, aging, and developing diagnostic tools.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

People with primary immunodeficiencies often have frequent, severe, or unusual infections and may need special tests and management strategies.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

A mutation in the hairless gene speeds up severe itchy skin in mice on a special diet.

Certain gene variants are linked to a higher risk of polycystic ovary syndrome, hair loss, and obesity in women from western Saudi Arabia.

Alopecia areata causes unpredictable hair loss and requires personalized treatment.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Vitiligo causes white skin patches and can lead to psychological stress.

People with alopecia areata may have a higher risk of thyroid diseases.

Vitamin D receptor gene changes don't affect alopecia areata risk.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.